Table 3. Truncated O-GalNAcylation Is Predominantly Expressed in Epithelial Tumors but Barely Expressed in Healthy Tissues.
| tissue | antigen | % tumor positive | % normal positive | notes | ref |
|---|---|---|---|---|---|
| breast | Tn | 14/15 (93%) | 1/5 | lectin | (165) |
| sTn | 13/21 (62%) | B72.3 | (166) | ||
| T | 47/52 (90%) | 2/21 (10%) | adsorption | (167) | |
| two positives premalignant | |||||
| colon | Tn | 21/29 (72%) | 14% (n = 22) | VVA | (168) |
| sTn | 40/60 (67%) | 7/46 (15%) | HBSTn-1 | (169) | |
| 29/46 (63%) | |||||
| T | 21/29 (72%) | 0% (n = 22) | AH9-16 | (168) | |
| stomach | Tn | 96/163 (59%) | HPA | (170) | |
| sTn | 53/85 (62.3%) | TKH2 | (171) | ||
| T | 18/87 (20.7%) | 0/58 (0%) | (172) | ||
| lung | Tn | 84/93 (90%) | HPA | (173) | |
| sTn | 26/27 (96%) | B72.3 | (174) | ||
| ovarian | sTn | 40/40 (100%) | B72.3 | (174) | |
| bladder | Tn | 27/34 (77%) | 0/10 (0%) | BaGs2 | (175) |
| sTn | 1/34 (3%) | 1/10 (10%) | TKH2 | (175) | |
| pancreas | Tn | 36/36 (100%) | 0/45 (0%) | CU-1 | (176) |
| sTn | 36/36 (100%) | TKH2 | (176) | ||
| T | 29/36 (81%) | PNA | (176) |